Clinical Trials

The Baird Institute runs and participates in many clinical trials. We also contribute to the Australian & New Zealand Society of Cardiac & Thoracic Surgery Database through their partnership with Royal Prince Alfred Hospital.

Lisa Turner and Lorna Beattie have over 30 years experience between them.

Lisa has been working in cardiovascular research since 2004.  She is the Cardiovascular Research Clinical Nurse Consultant (CNC) at Royal Prince Alfred Hospital (RPAH). Lorna joined The Baird Institute team two years ago and works alongside Lisa as the Clinical Trials Nurse Consultant (CNC). They have over 30 years cardiothoracic and vascular surgery nursing experience between them. Such experience has equipped them with the essential skills required to manage the many and varied Cardiovascular Clinical Trials and associated databases.

COMMUNICATION

One of the most important aspects of Lisa and Lorna’s job is communication, both with and between the patients, staff and medical teams. They are passionate about ensuring patients are well informed about the various research projects relating to their particular surgery. As well. they are given the opportunity to choose to participate in the associated research.

EDUCATION

Education also forms a large part of what Lisa and Lorna do; educating staff on study protocol and ensuring the study teams have a high level of protocol completion and adherence. They also manage patient and staff education in regards to each trial.

CO-ORDINATION

All logistics relating to the trials, are also managed by Lisa and Lorna.  Their tasks include managing the screening, recruitment, data collection and ethics reporting for the trials, ensuring all patient follow-up as well as updating the associated databases for the clinical trials conducted through The Baird Institute and RPA.

Along with all of the above, they find time to assist medical students with MD projects through the University of Sydney.

You can support The Baird Institute by making a once-off donation, leaving a bequest, volunteering time or services, or become a partner providing ongoing support.

Our current and completed trials and registries are listed below:

Current Trials

Cardiothoracic Clinical Trials

Name of Project Project Status
CardioNAD
Determining Feasibility of Human Myocardial NAD+ Replenishment using Nicotinamide Riboside Supplementation.		 Approval granted in January 2024. 1 patient recruited to date.
Regeneration
The intrinsic regenerative capacity of the adult human heart in ischaemic heart disease.		 HREC Approval granted in December 2023. Awaiting site specific approval from ethics to commence recruitment at RPAH

COPOC
A prospective randomised placebo-controlled double-blinded study to assess the role of colchicine in decreasing myocardial damage post cardiac surgery

41 patients recruited to date . Aiming for a total of 204.
Recruitment has been difficult dues to various restrictions during COVID-19

TRiCS IV
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
An international, multi-centre, randomized controlled trial to assess transfusion thresholds in younger
patients undergoing cardiac surgery

TRICS IV commenced at RPAH in December 2023. 1 patient recruited to date. TRiCS IV follows on from TRiCS III which took place in RPAH in 2015 to 2016. TRiCS III found that a restrictive transfusion strategy was not inferior to a liberal transfusion strategy, other than in a younger population.

CLiP II
Cryopreserved vs Liquid Platelets for surgical bleeding.
 A phase III multicentre blinded randomised controlled clinical non-inferiority trial of cryopreserved platelets vs. conventional liquid-stored platelets for the management of surgical bleeding

The pilot study CLiP-1, ran at RPAH from 2015 which tested the protocol for a definitive clinical trial of this technology. 31 patients recruited at RPAH to date.

Thoracic aortic surgery database and tissue bank

Recruiting all aortic surgery patients. Over 200 patients recruited to date

Molecular Studies in Human Hypertrophic Cardiomyopathy Tissue Bank

Recruiting all myomectomy surgery patients. Total 50 patients recruited to date

Cardiothoracic Surgery Biobank

Recruiting patients having Valve surgery. 37 patients recruited to date.

Sydney Cardiothoracic Surgeons Database/ ANZSCTS database export

All cardiac surgery patients
Approximately 550 Patients per year
The database allows for national benchmarking in cardiac surgery but also assists with quality improvement within RPAH

Vascular Surgery Clinical Trials

Name of Project Project Status
Alucent AVF
Safety and Feasability of the Vessel restoration system (VRS) to promote the physiologic and functional maturation of upper extremity Arteriovenous Fistula (AVF) formation in patients with chronic kidney disease.		 Approved to commence in December 2023 and currently in progress.

The RPAH Vascular Surgery Tissue Bank and Database

Recruiting patients having carotid and femoral artery surgery to remove plaque and abdominal aortic surgery.
29 patient recruited to date

GREAT
‘Global Registry for Endovascular Aortic Treatment’

81 Pts recruited at RPAH. Follow up only

MAT - The Metformin Aneurysm Trial
An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel-group, randomised controlled trial to determine the effect of metformin on abdominal aortic aneurysm (AAA) associated events, including AAA repair and AAA mortality (due to aneurysm rupture).

1 patient recruited in RPAH to date.
Patients with abdominal aneurysms which do not require surgery within 12 months are recruited.

Prevision
Prospective, Multicenter, Single Arm, Non-Randomized, Study of BD™ Sirolimus Drug Coated Balloon Catheter for Treatment of Femoropopliteal Arteries

1 patient recruited to date.
Patients undergoing treatment of arterial disease who require balloon catheter treatment of lower limb arteries are recruited.

T2EL
Vascular endothelial growth factor levels in type 2 endoleak requiring intervention.
This is an investigator-initiated study by one of RPAH’s vascular surgeons. He is investigating whether biomarkers may explain the behaviour of type II endoleaks

30 patients recruited to date.
Only patients with a type 2 endoleak need to be recruited. The other 2 groups, 1. Patients having an aortic stent, 2. A control group, have been recruited

Understanding Cellular Dysfunction in Atherosclerotic vascular disease.
This is an investigator-initiated study by one of RPAH’s vascular surgeons. He is hoping to understand the changes to genes and proteins in atherosclerosis.

41 patients have been recruited to date.
Patients having surgery for removal of carotid or femoral plaque, or lower limb amputation are being recruited

Completed Trials

Cardiothoracic Clinical Trials

Name of Project Project Status

Vision
Cardiac Surgery
‘Vascular events in Surgery patients cohort evaluation – Cardiac Surgery’

Recruitment ceased in 2020 and follow-up is complete. Due to the large amount of data collected, there continue to be data queries. There has been 1 publication with many more to come.

Frailty assessment in Cardiac surgery

Recruited patients having Cardiac surgery over 70 years of age.

Vascular Surgery Clinical Trials

Name of Project Project Status

INFINITE-OUS
‘Investigation of femoro-popliteal in situ valve formation with the InterVene System’
The trial is aiming to make a valve in the vein of people who have severe venous insufficiency

Recruited total 3 patients since June 2018.
2 completed follow up.
1 in follow up phase

Chrysalis
A Prospective, Multi-Center, Single-Arm Study Assessing the Clinical Use of the CATERPILLAR™ Arterial Embolization Device System for Arterial Embolization in the Peripheral Vasculature

2 patients recruited at RPAH.
Completed in November 2020 and published in November 2022

Pulse Modulation study
The Brain Protection Company Pty Ltd (BPCo) Extravascular Carotid Artery Pulse Modulation Device: First In Human Study

RPAH recruited 2 patients for the trial. Unfortunately, COVID-19 made recruitment and funding difficult. The trial ceased in August 2022.

VERNACULAR - The BARD VENOVO TM
Venous Stent Study ‘A prospective, Non-randomised, multicentre, single arm study of the treatment of ilio-femoral occlusive disease — An assessment for effectiveness and safety’.

1 patient recruited at RPAH to add to total of 170 internationally.
The trial was completed in 2020 and published in 2021.

ENGAGE
Endurant Stent Graft Natural Selection Global Post Market Registry.

Total of 12 patients recruited with four of those 12 being followed up for 6-10 years.
The 10-year follow-up was completed in 2022.

Our Mission

Our mission is to foster research and apply science to improve the outcomes for patients facing heart or lung surgery.

Donate by Phone

+61 2 9550 2350

Donate Now
Subscribe to Our Newsletter

Share with friends

About Us

Resources

You Can Help

The Baird Institute is a Registered Australian Charity

The Baird Institute is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). Eligible tax-deductible donations have Deductible Gift Recipient (DGR) status with the Australian Tax Office.

All content © 2025 The Baird Institute. All rights reserved. ABN 38 096 746 806.

Site by Weber Design Studio

The Baird Institute

Royal Prince Alfred Hospital
Cardiothoracic Department, Level 7,
50 Missenden Road, Camperdown, NSW, 2050

Stay in the loop

Subscribe to our Heart to Heart Newsletter to keep up with the latest developments in heart and lung research from The Baird Institute.

Honour a Loved One

  • Fundraise in memory of someone special to you.

Challenge Yourself

  • Run a marathon
  • Do a long bike ride
  • Walk 10km each day for a month
  • Do 50 sit ups every day for a week
  • Join an organised event such as the City to Surf

Organise a community event

  • Have a backyard sausage sizzle
  • Host a trivia night

Seek sponsorship to help you quit those bad habits

  • Give up smoking
  • Refrain from alcohol for a month or more

Celebrate Through Giving

  • Choose to give on your birthday: Instead of giving you gifts, ask your friends and family to donate to The Baird Institute.
  • Say “I do” to improving the lives of heart and lung patients: Invite guests to donate to The Baird Institute on your wedding day
  • Turn anniversaries or personal milestones into fundraising events.

Create a CrowdRaiser on GiveNow

  1. Go to CrowdRaiser for The Baird Institute.
  2. Click on the button “Fundraise for this cause” – just under the header image.
  3. Create your Crowdraiser. Fill in the requested details.
  4. Customise your campaign. Add images and messages to make your CrowdRaiser unique.
  5. Share the link to your fundraising page via email, social media, or any way you like.
  6. Let us know via [email protected] that you have created a fundraiser so we can say thank you.

Join a community passionate about making a difference. GiveNow provides a dedicated platform for Australian charities, ensuring your efforts directly support our mission.

Start a Facebook Fundraiser

  1. Go to Facebook fundraisers.
  2. Click on the blue button – “Select nonprofit”
  3. Search for and select The Baird Institute
  4. Set your fundraising target
  5. Choose your campaign end date & a title for your Fundraiser
  6. Personalise your fundraiser: Use the existing wording and photos or choose your own.
  7. Click on ‘Create’.
  8. Invite friends and family. Share the link for your fundraiser and encourage others to contribute.
  9. Let us know via [email protected] that you have created a fundraiser so we can say thank you.

Celebrate where your friends and family connect. Leverage your social network to make a real impact.